We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21.9B
AUM Growth
+$870M
Cap. Flow
-$433M
Cap. Flow %
-1.98%
Top 10 Hldgs %
43.67%
Holding
276
New
31
Increased
44
Reduced
103
Closed
5

Top Sells

Rank Stock Value
1
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$43.3M
2
TGT icon
Target
TGT
+$39.5M
3
XOM icon
ExxonMobil
XOM
+$32.7M
4
AAPL icon
Apple
AAPL
+$31.4M
5
HSBC icon
HSBC
HSBC
+$27.6M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.8%
2 Energy 25.94%
3 Financials 12.03%
4 Healthcare 10.86%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPT icon
76
Camden Property Trust
CPT
$11.5B
$18.4M 0.08%
257,900
TFCF
77
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$18.1M 0.08%
527,460
-21,115
-4% -$699K
LECO icon
78
Lincoln Electric
LECO
$14.1B
$17.3M 0.08%
248,200
BAC icon
79
Bank of America
BAC
$429B
$17.1M 0.08%
1,115,256
-54,063
-5% -$840K
NWSA icon
80
News Corp Class A
NWSA
$15.6B
$16.7M 0.08%
927,004
-46,680
-5% -$806K
ARGO
81
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$15.9M 0.07%
433,672
TWX
82
DELISTED
Time Warner Inc
TWX
$15.1M 0.07%
215,409
-9,401
-4% -$618K
RNET
83
DELISTED
RigNet, Inc.
RNET
$14.3M 0.07%
265,106
T icon
84
AT&T
T
$164B
$13.9M 0.06%
520,169
-2,558
-0.5% -$68.5K
ZTS icon
85
Zoetis
ZTS
$32.7B
$13.6M 0.06%
419,890
+101,436
+32% +$3.11M
FMX icon
86
Fomento Económico Mexicano
FMX
$41.2B
$12.5M 0.06%
133,960
-550
-0.4% -$52.2K
MDT icon
87
Medtronic
MDT
$112B
$10.1M 0.05%
158,912
-102,030
-39% -$6.2M
EQNR icon
88
Equinor
EQNR
$97.3B
$10.1M 0.05%
327,793
-12,550
-4% -$378K
TDY icon
89
Teledyne Technologies
TDY
$29.2B
$9.71M 0.04%
99,903
SBR
90
Sabine Royalty Trust
SBR
$1.06B
$9.17M 0.04%
151,249
BSY
91
DELISTED
BRITISH SKY BRDCSTNG ADS (EACH REPTG 4 ORD SHS)
BSY
$8.76M 0.04%
139,640
WPZ
92
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$8.72M 0.04%
170,471
-4,012
-2% -$198K
SLB icon
93
SLB Ltd
SLB
$72.7B
$8.69M 0.04%
44,368
+3,125
+8% +$322K
MMM icon
94
3M
MMM
$91.8B
$8.23M 0.04%
68,737
-508
-0.7% -$59.6K
ALG icon
95
Alamo Group
ALG
$1.91B
$8.2M 0.04%
151,500
MSFT icon
96
Microsoft
MSFT
$2.9T
$8.09M 0.04%
193,884
-6,151
-3% -$249K
BTI icon
97
British American Tobacco
BTI
$136B
$8.08M 0.04%
135,696
+20,950
+18% +$1.23M
CNQ icon
98
Canadian Natural Resources
CNQ
$96.9B
$7.33M 0.03%
330,010
+53,338
+19% +$1.07M
BRK.B icon
99
Berkshire Hathaway Class B
BRK.B
$1.1T
$6.69M 0.03%
52,880
+1,000
+2% +$127K
ANAT
100
DELISTED
American National Group, Inc. Common Stock
ANAT
$6.16M 0.03%
53,931

Similar funds

Fayez Sarofim & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Fayez Sarofim & Co held 276 positions worth $21.9B, up 4.1% from $21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q2 2014 filing shows 31 new, 44 increased, 103 reduced and 5 closed positions. Its largest new stake was AB InBev: 497,729 shares worth $57.2M. The largest sale was Royal Dutch Shell PLC ADS Class A, an estimated $43.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 28% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q2 2014 buy was AB InBev: 497,729 shares worth $57.2M.
  • Fayez Sarofim & Co added most to Twenty-First Century Fox, Inc. Class A in Q2 2014, an estimated $25.7M increase.
  • Fayez Sarofim & Co's biggest Q2 2014 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $43.3M.
  • Fayez Sarofim & Co fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $510K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $21.9B portfolio in Q2 2014.
  • Fayez Sarofim & Co opened 31 new positions and closed 5 in Q2 2014.
  • Fayez Sarofim & Co's portfolio value rose 4.1% quarter-over-quarter to $21.9B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2014, filed 14 Aug 2014.